Page last updated: 2024-11-10

blister

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

blebbistatin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

blebbistatin : A pyrroloquinoline that is 1,2,3,3a-tetrahydro-H-pyrrolo[2,3-b]quinolin-4-one substituted by a hydroxy group at position 3a, a methyl group at position 6 and a phenyl group at position 1. It acts as an inhibitor of ATPase activity of non-muscle myosin II. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3476986
CHEMBL ID1328324
CHEBI ID75379
SCHEMBL ID4330339
MeSH IDM0002668

Synonyms (82)

Synonym
CBIOL_002055
bleb
HMS3268C20
BRD-A75817871-001-02-6
PROBES1_000320
IDI1_033944
BIO2_000194
BIO2_000674
BIO1_000341
BIO1_001319
BIO1_000830
BSPBIO_001474
BCBCMAP01_000109
UPCMLD-DP100:001
blebbistatin
UPCMLD-DP100
PROBES2_000455
PROBES1_000318
UPCMLD-DP100:002
(+/-)-blebbistatin
NCGC00025281-03
NCGC00025281-04
NCGC00025281-05
KBIO3_000387
KBIO2_000194
KBIO3_000388
KBIOSS_000194
KBIO2_002762
KBIO2_005330
KBIOGR_000194
NCGC00025281-06
HMS1989J16
HMS1361J16
HMS1791J16
3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one
FT-0663412
FT-0663411
FT-0663410
SCHEMBL4330339
674289-55-5
A835747
6-methyl-3a-oxidanyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one
NCGC00025281-07
CHEMBL1328324 ,
CHEBI:75379 ,
3a-hydroxy-6-methyl-1-phenyl-1,2,3,3a-tetrahydro-4h-pyrrolo[2,3-b]quinolin-4-one
1-phenyl-1,2,3,4-tetrahydro-4-hydroxypyrrolo(2.3-b)-7-methylquinolin-4-one
unii-20wc4j7cq6
20wc4j7cq6 ,
(+-)-blebbistatin
( inverted exclamation marka)-blebbistatin
EI-315
MLS006010843
smr004701769
blebbistatin [mi]
1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4h-pyrrolo(2,3-b)quinolin-4-one
4h-pyrrolo(2,3-b)quinolin-4-one, 1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-
(+/-)-1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4h-pyrrolo[2,3-b]quinolin-4-one
1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4h-pyrrolo[2,3-b]quinolin-4-one
LZAXPYOBKSJSEX-UHFFFAOYSA-N
AKOS024456763
HMS3648G12
HMS3402J16
3a-hydroxy-6-methyl-1-phenyl-3,3a-dihydro-1h-pyrrolo[2,3-b]quinolin-4(2h)-one
SR-01000597498-1
sr-01000597498
blebbistain
P16952
AS-53726
HY-13813
CS-0007920
bdbm50449472
BCP07571
Q27145262
mfcd04113775
HMS3676F12
SR-01000597498-2
HMS3412F12
DTXSID501017342
blebbistatin is known as a racemic mixture of (-)-blebbistatin and (+)-blebbistatin.
3a-hydroxy-6-methyl-1-phenyl-2h,3h-pyrrolo[2,3-b]quinolin-4-one
EX-A8013G

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Moreover, activation of mTORC1 signalling displays a positive dose-response relationship with peak tension."( Activation of mTORC1 signalling in rat skeletal muscle is independent of the EC-coupling sequence but dependent on tension per se in a dose-response relationship.
de Paoli, FV; Kristensen, AM; Overgaard, K; Rindom, E; Vissing, K, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
inhibitorA substance that diminishes the rate of a chemical reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
pyrroloquinoline
cyclic ketone
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
tertiary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing two organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency7.61110.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.86310.180013.557439.8107AID1460
regulator of G-protein signaling 4Homo sapiens (human)Potency0.08440.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Myosin-2 heavy chainDictyostelium discoideumIC50 (µMol)4.90004.90004.90004.9000AID1360372
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)150.00000.00002.398310.0000AID1360386
Myosin-9Homo sapiens (human)IC50 (µMol)4.00004.00004.00004.0000AID1360374
Myosin-10Homo sapiens (human)IC50 (µMol)4.60004.60004.60004.6000AID1360375
Myosin-7Sus scrofa (pig)IC50 (µMol)1.20001.20001.20001.2000AID1360381
Myosin-4Oryctolagus cuniculus (rabbit)IC50 (µMol)0.22000.22000.22000.2200AID1360380
Myosin-14Mus musculus (house mouse)IC50 (µMol)3.20003.20003.20003.2000AID1360377
Nonmuscle myosin heavy chainGallus gallus (chicken)IC50 (µMol)1.80001.80001.80001.8000AID1360376
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (48)

Processvia Protein(s)Taxonomy
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
actin filament-based movementMyosin-9Homo sapiens (human)
meiotic spindle organizationMyosin-9Homo sapiens (human)
angiogenesisMyosin-9Homo sapiens (human)
in utero embryonic developmentMyosin-9Homo sapiens (human)
establishment of T cell polarityMyosin-9Homo sapiens (human)
plasma membrane repairMyosin-9Homo sapiens (human)
membrane protein ectodomain proteolysisMyosin-9Homo sapiens (human)
phagocytosis, engulfmentMyosin-9Homo sapiens (human)
integrin-mediated signaling pathwayMyosin-9Homo sapiens (human)
myoblast fusionMyosin-9Homo sapiens (human)
regulation of cell shapeMyosin-9Homo sapiens (human)
protein transportMyosin-9Homo sapiens (human)
actin cytoskeleton organizationMyosin-9Homo sapiens (human)
actin filament-based movementMyosin-9Homo sapiens (human)
platelet formationMyosin-9Homo sapiens (human)
monocyte differentiationMyosin-9Homo sapiens (human)
actomyosin structure organizationMyosin-9Homo sapiens (human)
lysosome localizationMyosin-9Homo sapiens (human)
cytokinetic processMyosin-9Homo sapiens (human)
uropod organizationMyosin-9Homo sapiens (human)
endodermal cell differentiationMyosin-9Homo sapiens (human)
blood vessel endothelial cell migrationMyosin-9Homo sapiens (human)
regulated exocytosisMyosin-9Homo sapiens (human)
leukocyte migrationMyosin-9Homo sapiens (human)
establishment of meiotic spindle localizationMyosin-9Homo sapiens (human)
cortical granule exocytosisMyosin-9Homo sapiens (human)
platelet aggregationMyosin-9Homo sapiens (human)
negative regulation of actin filament severingMyosin-9Homo sapiens (human)
positive regulation of protein processing in phagocytic vesicleMyosin-9Homo sapiens (human)
regulation of plasma membrane repairMyosin-9Homo sapiens (human)
mitotic cytokinesisMyosin-10Homo sapiens (human)
actin filament-based movementMyosin-10Homo sapiens (human)
cell adhesionMyosin-10Homo sapiens (human)
actomyosin structure organizationMyosin-10Homo sapiens (human)
positive regulation of protein secretionMyosin-10Homo sapiens (human)
mitotic cytokinesisMyosin-10Homo sapiens (human)
regulation of cell shapeMyosin-10Homo sapiens (human)
signal transductionUnconventional myosin-XBos taurus (cattle)
regulation of cell shapeUnconventional myosin-XBos taurus (cattle)
cytoskeleton-dependent intracellular transportUnconventional myosin-XBos taurus (cattle)
regulation of filopodium assemblyUnconventional myosin-XBos taurus (cattle)
sensory perception of soundUnconventional myosin-XVHomo sapiens (human)
locomotory behaviorUnconventional myosin-XVHomo sapiens (human)
response to light stimulusUnconventional myosin-XVHomo sapiens (human)
inner ear morphogenesisUnconventional myosin-XVHomo sapiens (human)
actin filament organizationUnconventional myosin-XVHomo sapiens (human)
endocytosisUnconventional myosin-XVHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (33)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
microfilament motor activityMyosin-9Homo sapiens (human)
actin filament bindingMyosin-9Homo sapiens (human)
microfilament motor activityMyosin-9Homo sapiens (human)
RNA bindingMyosin-9Homo sapiens (human)
cytoskeletal motor activityMyosin-9Homo sapiens (human)
actin bindingMyosin-9Homo sapiens (human)
integrin bindingMyosin-9Homo sapiens (human)
protein bindingMyosin-9Homo sapiens (human)
calmodulin bindingMyosin-9Homo sapiens (human)
ATP bindingMyosin-9Homo sapiens (human)
protein domain specific bindingMyosin-9Homo sapiens (human)
identical protein bindingMyosin-9Homo sapiens (human)
protein homodimerization activityMyosin-9Homo sapiens (human)
protein-membrane adaptor activityMyosin-9Homo sapiens (human)
ADP bindingMyosin-9Homo sapiens (human)
cadherin bindingMyosin-9Homo sapiens (human)
actin filament bindingMyosin-9Homo sapiens (human)
microfilament motor activityMyosin-10Homo sapiens (human)
actin filament bindingMyosin-10Homo sapiens (human)
microfilament motor activityMyosin-10Homo sapiens (human)
actin bindingMyosin-10Homo sapiens (human)
protein bindingMyosin-10Homo sapiens (human)
calmodulin bindingMyosin-10Homo sapiens (human)
ATP bindingMyosin-10Homo sapiens (human)
RNA stem-loop bindingMyosin-10Homo sapiens (human)
ADP bindingMyosin-10Homo sapiens (human)
mRNA 5'-UTR bindingMyosin-10Homo sapiens (human)
actin filament bindingMyosin-10Homo sapiens (human)
microfilament motor activityUnconventional myosin-XBos taurus (cattle)
calmodulin bindingUnconventional myosin-XBos taurus (cattle)
ATP bindingUnconventional myosin-XBos taurus (cattle)
phosphatidylinositol-3,4,5-trisphosphate bindingUnconventional myosin-XBos taurus (cattle)
actin filament bindingUnconventional myosin-XBos taurus (cattle)
plus-end directed microfilament motor activityUnconventional myosin-XBos taurus (cattle)
microfilament motor activityUnconventional myosin-VaMus musculus (house mouse)
calmodulin bindingUnconventional myosin-XVHomo sapiens (human)
ATP bindingUnconventional myosin-XVHomo sapiens (human)
microfilament motor activityUnconventional myosin-XVHomo sapiens (human)
actin filament bindingUnconventional myosin-XVHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (39)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
focal adhesionMyosin-9Homo sapiens (human)
COP9 signalosomeMyosin-9Homo sapiens (human)
stress fiberMyosin-9Homo sapiens (human)
ruffleMyosin-9Homo sapiens (human)
immunological synapseMyosin-9Homo sapiens (human)
uropodMyosin-9Homo sapiens (human)
nucleusMyosin-9Homo sapiens (human)
cytoplasmMyosin-9Homo sapiens (human)
spindleMyosin-9Homo sapiens (human)
actomyosin contractile ringMyosin-9Homo sapiens (human)
cytosolMyosin-9Homo sapiens (human)
plasma membraneMyosin-9Homo sapiens (human)
brush borderMyosin-9Homo sapiens (human)
adherens junctionMyosin-9Homo sapiens (human)
cytoplasmic side of plasma membraneMyosin-9Homo sapiens (human)
actin cytoskeletonMyosin-9Homo sapiens (human)
membraneMyosin-9Homo sapiens (human)
nuclear bodyMyosin-9Homo sapiens (human)
cell leading edgeMyosin-9Homo sapiens (human)
neuromuscular junctionMyosin-9Homo sapiens (human)
cleavage furrowMyosin-9Homo sapiens (human)
actomyosinMyosin-9Homo sapiens (human)
cortical granuleMyosin-9Homo sapiens (human)
extracellular exosomeMyosin-9Homo sapiens (human)
myosin II filamentMyosin-9Homo sapiens (human)
myosin II complexMyosin-9Homo sapiens (human)
protein-containing complexMyosin-9Homo sapiens (human)
cytoplasmMyosin-9Homo sapiens (human)
myosin filamentMyosin-9Homo sapiens (human)
postsynaptic actin cytoskeletonMyosin-10Homo sapiens (human)
stress fiberMyosin-10Homo sapiens (human)
nucleusMyosin-10Homo sapiens (human)
cytoplasmMyosin-10Homo sapiens (human)
cytosolMyosin-10Homo sapiens (human)
cell cortexMyosin-10Homo sapiens (human)
lamellipodiumMyosin-10Homo sapiens (human)
midbodyMyosin-10Homo sapiens (human)
cleavage furrowMyosin-10Homo sapiens (human)
actomyosinMyosin-10Homo sapiens (human)
extracellular exosomeMyosin-10Homo sapiens (human)
myosin II filamentMyosin-10Homo sapiens (human)
myosin complexMyosin-10Homo sapiens (human)
myosin II complexMyosin-10Homo sapiens (human)
myosin filamentMyosin-10Homo sapiens (human)
cytoplasmMyosin-10Homo sapiens (human)
ruffleUnconventional myosin-XBos taurus (cattle)
cytosolUnconventional myosin-XBos taurus (cattle)
cell cortexUnconventional myosin-XBos taurus (cattle)
lamellipodiumUnconventional myosin-XBos taurus (cattle)
filopodium membraneUnconventional myosin-XBos taurus (cattle)
filopodium tipUnconventional myosin-XBos taurus (cattle)
myosin complexUnconventional myosin-XBos taurus (cattle)
cytosolUnconventional myosin-VaMus musculus (house mouse)
cytosolMyosin heavy chain, non-muscleDrosophila melanogaster (fruit fly)
stereociliumUnconventional myosin-XVHomo sapiens (human)
extracellular exosomeUnconventional myosin-XVHomo sapiens (human)
myosin complexUnconventional myosin-XVHomo sapiens (human)
cytoplasmUnconventional myosin-XVHomo sapiens (human)
actin-based cell projectionUnconventional myosin-XVHomo sapiens (human)
actin cytoskeletonUnconventional myosin-XVHomo sapiens (human)
membraneUnconventional myosin-XVHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1360387Inhibition of human myosin 15 by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360383Inhibition of rat myosin 1b by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360381Inhibition of pig beta cardiac myosin 2 by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360414Inhibition of Bos taurus smooth muscle myosin 2 ATPase activity2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360385Inhibition of mouse myosin 5a by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360379Inhibition of bay scallop striated muscle myosin heavy chain2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360372Inhibition of RLC-phosphorylated Dictyostelium discoideum myosin 2 ATPase activity by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360378Inhibition of chicken smooth muscle myosin 2 ATPase activity preincubated for 60 mins followed by ATP addition measured after 10 mins by malachite green based assay2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360375Inhibition of human non-muscle myosin 2b2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360380Inhibition of rabbit skeletal muscle myosin 22018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360376Inhibition of chicken non-muscle myosin 2b by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360384Inhibition of dephosphorylated Acanthamoeba muscle myosin 1c by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360386Inhibition of bovine myosin x by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360415Inhibition of Meleagris gallopavo smooth muscle myosin 2 ATPase activity2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360377Inhibition of mouse non-muscle myosin 2c2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360374Inhibition of human non-muscle myosin 2a2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360373Inhibition of dephosphorylated Acanthamoeba non muscle myosin 2 by NADH-coupled spectrophotometric analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID1360382Inhibition of fruit fly non-muscle myosin 22018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (457)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's138 (30.20)29.6817
2010's283 (61.93)24.3611
2020's36 (7.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 129.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index129.30 (24.57)
Research Supply Index6.13 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index266.25 (26.88)
Search Engine Supply Index2.22 (0.95)

This Compound (129.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (1.30%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other454 (98.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]